
Quarterly Result29 Oct 2026, 12:28 pm
Lincoln Pharmaceuticals Declares Un-Audited Q2 FY27 Results
AI Summary
Lincoln Pharmaceuticals Ltd announced its un-audited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved the standalone and consolidated results, along with the limited review report from the auditors. The company will publish extracts of these results, which will also be available on its website. Financial highlights for the period were also shared.
Key Highlights
- Board approved un-audited financial results for Q2 FY27.
- Results are for both standalone and consolidated financials.
- Limited review report from auditors is included.
- Financial highlights for the period were released.
- Results will be available on the company website.
Price Impact
More from LINCOLN